BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28393206)

  • 1. Prognostic role of TPL2 in early‑stage non‑small cell lung cancer.
    Boldrini L; Giordano M; Servadio A; Niccoli C; Bertoglio P; Lucchi M; Melfi F; Mussi A; Fontanini G
    Mol Med Rep; 2017 Jun; 15(6):3451-3458. PubMed ID: 28393206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells.
    Li Z; Zhu W; Xiong L; Yu X; Chen X; Lin Q
    Oncotarget; 2016 Sep; 7(38):61366-61377. PubMed ID: 27542260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma.
    Cooper WA; Tran T; Vilain RE; Madore J; Selinger CI; Kohonen-Corish M; Yip P; Yu B; O'Toole SA; McCaughan BC; Yearley JH; Horvath LG; Kao S; Boyer M; Scolyer RA
    Lung Cancer; 2015 Aug; 89(2):181-8. PubMed ID: 26024796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
    Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
    Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
    Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
    Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
    Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of miR‑124a as a novel diagnostic and prognostic biomarker in non‑small cell lung cancer for chemotherapy.
    Luo P; Yang Q; Cong LL; Wang XF; Li YS; Zhong XM; Xie RT; Jia CY; Yang HQ; Li WP; Cong XL; Xia Q; Fu D; Zeng QH; Ma YS
    Mol Med Rep; 2017 Jul; 16(1):238-246. PubMed ID: 28534972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
    Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
    Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variant of BCL3 gene is strongly associated with five-year survival of non-small-cell lung cancer patients.
    Dimitrakopoulos FI; Antonacopoulou AG; Kottorou A; Marousi S; Koukourikou I; Kalofonou M; Panagopoulos N; Scopa C; Dougenis D; Papadaki H; Papavassiliou AG; Kalofonos HP
    Lung Cancer; 2015 Sep; 89(3):311-9. PubMed ID: 26122346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of miR-503 expression predicate advanced mythological features and poor prognosis in patients with NSCLC.
    Liu L; Qu W; Zhong Z
    Int J Clin Exp Pathol; 2015; 8(5):5609-13. PubMed ID: 26191272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer.
    Kong F; Gao F; Chen J; Sun Y; Zhang Y; Liu H; Li X; Yang P; Zheng R; Liu G; Jia Y
    Oncotarget; 2016 Aug; 7(35):56193-56199. PubMed ID: 27486880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiRNA-200a expression is inverse correlation with hepatocyte growth factor expression in stromal fibroblasts and its high expression predicts a good prognosis in patients with non-small cell lung cancer.
    Chen Y; Du M; Wang J; Xing P; Zhang Y; Li F; Lu X
    Oncotarget; 2016 Jul; 7(30):48432-48442. PubMed ID: 27374174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
    Yang J; Liu H; Wang H; Sun Y
    Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
    Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
    Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.
    Tang R; Zhong T; Dang Y; Zhang X; Li P; Chen G
    Clin Transl Oncol; 2016 Apr; 18(4):360-8. PubMed ID: 26307752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of CUG-binding protein 1 expression and vascular invasion after radical surgery for stage IB nonsmall cell lung cancer.
    Zhao J; Zhao Y; Xuan Y; Jiao W; Qiu T; Wang Z; Luo Y
    Indian J Cancer; 2015 Dec; 52 Suppl 2():e125-9. PubMed ID: 26728670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expression of ROR2 and Wnt5a cooperatively correlates with unfavorable prognosis in patients with non-small cell lung cancer.
    Lu C; Wang X; Zhu H; Feng J; Ni S; Huang J
    Oncotarget; 2015 Sep; 6(28):24912-21. PubMed ID: 26305508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the NEDD4L gene as a prognostic marker by integrated microarray analysis of copy number and gene expression profiling in non-small cell lung cancer.
    Sakashita H; Inoue H; Akamine S; Ishida T; Inase N; Shirao K; Mori M; Mimori K
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S590-8. PubMed ID: 23812770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tpl2 kinase impacts tumor growth and metastasis of clear cell renal cell carcinoma.
    Lee HW; Joo KM; Lim JE; Cho HJ; Cho HJ; Park MC; Seol HJ; Seo SI; Lee JI; Kim S; Jeong BC; Nam DH
    Mol Cancer Res; 2013 Nov; 11(11):1375-86. PubMed ID: 23982215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TPL2 kinase is a suppressor of lung carcinogenesis.
    Gkirtzimanaki K; Gkouskou KK; Oleksiewicz U; Nikolaidis G; Vyrla D; Liontos M; Pelekanou V; Kanellis DC; Evangelou K; Stathopoulos EN; Field JK; Tsichlis PN; Gorgoulis V; Liloglou T; Eliopoulos AG
    Proc Natl Acad Sci U S A; 2013 Apr; 110(16):E1470-9. PubMed ID: 23533274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.